US pharma market to reach $550bn by 2020
Mar 24, 2015 09:12:37 #
The company's latest report finds that this is a Compound Annual Growth Rate (CAGR) of 5.6%, and will be driven by a number of factors.
These include increased healthcare expenditure, an ageing population, the rising prevalence of chronic lifestyle diseases such as diabetes and obesity, universal and easy access to reimbursement for pharmaceutical product costs, and the 2010 Patient Protection and Affordable Care Act (PPACA
http://www.pmlive.com/pharma_news/us_pharma_market_to_reach_$550bn_by_2020_684238
These include increased healthcare expenditure, an ageing population, the rising prevalence of chronic lifestyle diseases such as diabetes and obesity, universal and easy access to reimbursement for pharmaceutical product costs, and the 2010 Patient Protection and Affordable Care Act (PPACA
http://www.pmlive.com/pharma_news/us_pharma_market_to_reach_$550bn_by_2020_684238
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.